The global allergy immunotherapy market size was valued at USD 1.58 billion in 2022. The market is anticipated to grow from USD 1.70 billion in 2023 to USD 3.20 billion by 2030, exhibiting a CAGR of 9.5% during the forecast period. The growing allergic population and heavy investments by significant players to develop novel immunotherapies are expected to support the allergy immunotherapy market growth. Rising awareness among consumers globally and government initiatives for developing immunotherapy products for untouched allergic conditions are expected to propel the market during the forecast period. Fortune Business Insights presents this information in their report titled “Global Allergy Immunotherapy Market, 2023–2030.” Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/sample/allergy-immunotherapy-market-100727 Key Takeaways:
  • Reduction in Patient Visits to the Clinics Hampered Market Growth Amid the Pandemic
  • Shifting Preference Towards Sublingual Immunotherapy (SLIT) Tablets and Drops Aided Market Expansion
  • Growing Prevalence of Allergies to Augment the Demand for Immunotherapy Drugs
  • High Cost of Treatment Coupled with Poor Adherence to Medication to Impede Market Growth
  • ALK-Abello Dominated the Market Owing to its Strong Presence and Robust Product Portfolio
List of Key Players Profiled in the Market Report:
  • ALK (Denmark)
  • Stallergenes Greer (Switzerland)
  • Allergy Therapeutics (U.K.)
  • HAL Allergy B.V. (Netherlands)
  • HollisterStier Allergy (U.S.)
  • Zhejiang Wolwo Bio-pharmaceutical Co., Ltd. (China)
  • LETIPharma (Spain)
  • Dermapharm Holding SE (Germany)
COVID-19 Impact: Fewer Patient Visits led to Sluggish Growth During Pandemic Stringent pandemic regulations during the COVID-19 pandemic reduced patient visits to clinics and hospitals, resulting in slow growth of the market. For instance, globally, patient visits declined by 93.0% in 2022, according to the European Academy of Allergy and Clinical Immunology’s survey in NCBI. To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/industry-reports/allergy-immunotherapy-market-100727 About Us: Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in. Contact Us: Fortune Business Insights™ Pvt. Ltd U.S.: +1 424 253 0390 U.K.: +44 2071 939123 APAC: +91 744 740 1245Email:[email protected]